Ethicon Announced European Approval and Introduction of ETHIZIA™ Hemostatic Sealing Patch Used to Stop Disruptive Bleeding
On November 15, 2023, Ethicon, a Johnson & Johnson MedTech company, received approval for ETHIZIA™, an adjunctive hemostat solution that has been clinically proven to achieve sustained hemostasis in difficult-to-control bleeding situations.
ETHIZIA Hemostatic Sealing Patch is the first and only hemostatic matrix made of a special synthetic polymer technology that is equally active and effective on both sides. Its ultimate adaptability is derived from its capacity to be trimmed, adjusted, pulled apart, rolled up, and otherwise handle...
